Literature DB >> 30713661

Effects of indoor coal fine particulate matter on the expression levels of inflammatory factors in ovalbumin-induced mice.

Jie Yu1, Yin Tang1, Jie Xu1.   

Abstract

Objective: Cooking and heating with coal is the main source of household air pollution in acid rain-plagued areas of China and is a leading contributor to disease burden. In this study, we investigated the adverse effects of exposure to indoor fine particulate matter emission from coal combustion on the expression levels of inflammatory factors in ovalbumin (OVA)-induced mice.
Methods: Forty BALB/c male mice were randomly divided into four groups (control group, PM2.5 group, OVA group, and OVA + PM2.5 group; n = 10) and treated with ovalbumin (OVA) or PM2.5, alone or together. Interleukin-4 (IL-4), interleukin-7 (IL-7), interleukin-8 (IL-8), interleukin-17 (IL-17), transforming growth factor β1 (TGF-β1), and interferon γ (IFN-γ) protein expression levels were measured in bronchoalveolar lavage fluid (BALF). Additionally, serum immunoglobulin (Ig) IgE and IgG1 levels were measured. The mRNA expression levels of IL-7 and IFN-γ in pulmonary tissue were also analyzed. Bronchoalveolar lavage (BAL), inflammatory cell counts, and histopathological examinations were also performed.
Results: Exposure to PM2.5 + OVA induced abnormal pathological changes and inflammatory responses in lungs compared to the control. The levels of IL-4, IL-7, IL-8 and IL-17 in BALF from the OVA + PM2.5 group were higher than those in BALF from the control group, OVA group, and PM2.5 group (P < 0.05). PM2.5 plus OVA significantly raised the serum IgE and IgG1 levels compared with the control group. An increasing IL-7 mRNA trend was found among the treatment groups (P < 0.05). The expression level of IFN-γ mRNA was significantly higher in the control group than in the other 3 groups (P < 0.05).
Conclusion: Indoor coal PM2.5 was sufficient by itself to cause inflammatory cellular infiltration of pulmonary tissue, leading to organelle injury and physiological structure change. Additionally, it promoted the occurrence and development of asthma by influencing the expression levels of IL-7 and various relevant inflammatory factors (such as IL-4 and IL-8) and changing the equilibrium between Treg and Th17 cells.

Entities:  

Year:  2018        PMID: 30713661      PMCID: PMC6334494          DOI: 10.1039/c8tx00221e

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  23 in total

1.  Contribution of solid fuel, gas combustion, or tobacco smoke to indoor air pollutant concentrations in Irish and Scottish homes.

Authors:  S Semple; C Garden; M Coggins; K S Galea; P Whelan; H Cowie; A Sánchez-Jiménez; P S Thorne; J F Hurley; J G Ayres
Journal:  Indoor Air       Date:  2011-11-09       Impact factor: 5.770

2.  Cigarette smoke dissociates inflammation and lung remodeling in OVA-sensitized and challenged mice.

Authors:  Deborah C Hizume; Alessandra C Toledo; Henrique T Moriya; Beatriz M Saraiva-Romanholo; Francine M Almeida; Fernanda M Arantes-Costa; Rodolfo P Vieira; Marisa Dolhnikoff; David Itiro Kasahara; Milton A Martins
Journal:  Respir Physiol Neurobiol       Date:  2012-03-15       Impact factor: 1.931

3.  Effect of different sensitizing doses of antigen in a murine model of atopic asthma.

Authors:  K Sakai; A Yokoyama; N Kohno; K Hiwada
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 4.  TH17 cells in asthma and COPD.

Authors:  John F Alcorn; Christopher R Crowe; Jay K Kolls
Journal:  Annu Rev Physiol       Date:  2010       Impact factor: 19.318

Review 5.  Th17 cells: new players in asthma pathogenesis.

Authors:  L Cosmi; F Liotta; E Maggi; S Romagnani; F Annunziato
Journal:  Allergy       Date:  2011-03-06       Impact factor: 13.146

6.  Lung mechanics and histology during sevoflurane anesthesia in a model of chronic allergic asthma.

Authors:  Shirley Moreira Burburan; Debora Gonçalves Xisto; Halina Cidrini Ferreira; Douglas Dos Reis Riva; Giovanna Marcella Cavalcante Carvalho; Walter Araujo Zin; Patricia Rieken Macêdo Rocco
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

7.  Differences in cytotoxicity versus pro-inflammatory potency of different PM fractions in human epithelial lung cells.

Authors:  Maurizio Gualtieri; Johan Øvrevik; Jørn A Holme; M Grazia Perrone; Ezio Bolzacchini; Per E Schwarze; Marina Camatini
Journal:  Toxicol In Vitro       Date:  2009-09-20       Impact factor: 3.500

8.  IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells.

Authors:  O Abehsira-Amar; M Gibert; M Joliy; J Thèze; D L Jankovic
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice.

Authors:  M Das; A Ram; B Ghosh
Journal:  Inflamm Res       Date:  2003-03       Impact factor: 4.575

10.  Pulmonary arterial remodeling induced by a Th2 immune response.

Authors:  Eleen Daley; Claire Emson; Christophe Guignabert; Rene de Waal Malefyt; Jennifer Louten; Viswanath P Kurup; Cory Hogaboam; Laimute Taraseviciene-Stewart; Norbert F Voelkel; Marlene Rabinovitch; Ekkehard Grunig; Gabriele Grunig
Journal:  J Exp Med       Date:  2008-01-28       Impact factor: 14.307

View more
  3 in total

Review 1.  The Role and Potential Pathogenic Mechanism of Particulate Matter in Childhood Asthma: A Review and Perspective.

Authors:  Xuchen Xu; Jianing Zhang; Xin Yang; Yuanyuan Zhang; Zhimin Chen
Journal:  J Immunol Res       Date:  2020-01-17       Impact factor: 4.818

2.  Human airway construct model is suitable for studying transcriptome changes associated with indoor air particulate matter toxicity.

Authors:  Maria-Elisa Nordberg; Martin Täubel; Pasi I Jalava; Kelly BéruBé; Arja Tervahauta; Anne Hyvärinen; Kati Huttunen
Journal:  Indoor Air       Date:  2020-01-23       Impact factor: 5.770

3.  Exploring the Potential Effects and Mechanisms of Asarum sieboldii Radix Essential Oil for Treatment of Asthma.

Authors:  Jae Min Han; Mi Hye Kim; La Yoon Choi; Gyeongsang Kim; Woong Mo Yang
Journal:  Pharmaceutics       Date:  2022-03-03       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.